The Consultant & Investment Group (AMM:CICO) 1-Year Sharpe Ratio: 0.08 (As of Jul. 12, 2026)


AMM:CICO The Consultant & Investment Group AMM:CICO
75 GF Score
Price JOD1.78
GF Value JOD2.21
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is The Consultant & Investment Group 1-Year Sharpe Ratio?

The Consultant & Investment Group AMM:CICO 75 1-Year Sharpe Ratio is 0.08 as of Jul. 12, 2026. GuruFocus rates AMM:CICO with a GF Score™ of 75/100 and a GF Value™ of JOD2.21 (Modestly Undervalued). The stock has 2 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-12), The Consultant & Investment Group's 1-Year Sharpe Ratio is 0.08.

The Consultant & Investment Group  (AMM:CICO) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

The Consultant & Investment Group 1-Year Sharpe Ratio Related Terms

AMM:CICO vs HCA, THC, DVA: 1-Year Sharpe Ratio Comparison

For the Medical Care Facilities subindustry, The Consultant & Investment Group's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Consultant & Investment Group 1-Year Sharpe Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, The Consultant & Investment Group's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where The Consultant & Investment Group's 1-Year Sharpe Ratio falls into.


AMM:CICO
75GF Score
The Consultant & Investment Group AMM:CICO
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Consultant & Investment Group 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.08 mean?
The Consultant & Investment Group (AMM:CICO) has a 1-Year Sharpe Ratio of 0.08 as of Jul. 12, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for The Consultant & Investment Group and its competitors.
Is The Consultant & Investment Group's 1-Year Sharpe Ratio too high?
The Consultant & Investment Group's current 1-Year Sharpe Ratio is 0.08. Overall, The Consultant & Investment Group has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Consultant & Investment Group's 1-Year Sharpe Ratio compare to HCA and THC?
The Consultant & Investment Group's 1-Year Sharpe Ratio of 0.08 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Healthcare Providers & Services company?
A good 1-Year Sharpe Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for The Consultant & Investment Group and its competitors. The Consultant & Investment Group's current 1-Year Sharpe Ratio is 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Consultant & Investment Group stock overvalued right now?
Based on GuruFocus' analysis, The Consultant & Investment Group (AMM:CICO) is currently considered Modestly Undervalued. The stock's GF Value™ is JOD2.21, compared to a current price of JOD1.78 — trading 19.5% below its estimated fair value. The current 1-Year Sharpe Ratio is 0.08. The Consultant & Investment Group's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For The Consultant & Investment Group (AMM:CICO), the current 1-Year Sharpe Ratio is 0.08 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Consultant & Investment Group (AMM:CICO) Overvalued in 2026?

Based on GuruFocus' analysis, The Consultant & Investment Group stock appears to be undervalued. The current stock price of JOD1.78 is trading 19.5% below its estimated GF Value™ of JOD2.21. GuruFocus considers The Consultant & Investment Group to be Modestly Undervalued.

Key valuation signals for AMM:CICO:

  • 1-Year Sharpe Ratio: 0.08
  • GF Value™: JOD2.21 vs. price of JOD1.78 (19.5% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the AMM:CICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Consultant & Investment Group Business Description

Address 44 Al Kindi Street, Wadi Saqrah, P.O. Box 840431, King Abdullah Gardens Cross, Amman, JOR, 11184
The Consultant & Investment Group is a Jordan-based company that engages in the healthcare and medical sector. It is engaged in the provision of medical care services. The company generates revenue from medical services and the sale of medicine and medical/ supplies are recognized. The company gains majority of revenue from Jordan. The Group principally operates only in the Hashemite Kingdom of Jordan.
75GF Score

Get the complete analysis for AMM:CICO

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD1.78
Price
JOD2.21
GF Value